-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Protara Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2017 to Q1 2024.
- Protara Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $23.1M, a 134% increase year-over-year.
- Protara Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $19.2M, a 63.9% decline from 2023.
- Protara Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $53.1M, a 255% increase from 2022.
- Protara Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $15M.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)